Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

Sell-side analyst rating changes are commonly relied upon by investors to buy, sell or hold and media reports of such changes frequently move individual stock prices. Portfolio managers should treat brokerage rating shifts as potential catalysts for short-term price moves and volatility, even when underlying fundamentals are unchanged.

Analysis

Sell-side analyst rating changes are commonly relied upon by investors to buy, sell or hold and media reports of such changes frequently move individual stock prices. Portfolio managers should treat brokerage rating shifts as potential catalysts for short-term price moves and volatility, even when underlying fundamentals are unchanged.